Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1206.00

7.05 (0.59%)

< Home < Back

Dr. Reddys Laboratories Ltd. News

>>

Dr. Reddy's Laboratories rises on getting USFDA’s approval for rituximab biosimilar

>>

Dr. Reddy's Laboratories gets USFDA’s approval for rituximab biosimilar

>>

Dr. Reddy’s Laboratories informs about press release

>>

Dr. Reddy's Laboratories hits 52-week low as its consolidated net profit drops 69% in Q1

>>

Dr. Reddy's Laboratories’ consolidated net profit drops 69% in Q1

>>

Dr. Reddy’s Laboratories informs about audio recordings of earnings call

>>

Dr. Reddy's Labs. - Quaterly Results

>>

Dr. Reddy’s Laboratories informs about audio recording of conference call

>>

Dr. Reddy’s Laboratories informs about analyst meet

>>

Dr Reddys Laboratories informs about AGM

<< < 1 2 3 ...144 > >>